Fig. 1: Study Design.

De-identified EHRs from patients with NSCLC or colorectal cancer were processed using an optical character recognition system and analyzed with neurosymbolic AI to extract 12 trial eligibility criteria. Clinical research coordinators reviewed randomized charts with AI augmentation or without AI support. Primary accuracy and efficiency assessments compared the Human-AI and the Human-Alone arms.